Looking for volunteers
A Multicenter Study of RUS NE
NCT06868186 · Hutom Corp · Updated 11 Sept 2025
- What is being tested
- RUS NE
- For
- Renal Tumors
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 19 years to 80 years. About 204 people. The full rules are on the registry page.
- Where
- South Korea (4 sites)
- When
- Starts or started 29 April 2025, ends 30 April 2026. Registered 10 March 2025.
- Results
- None posted yet.
In the researchers' words
This sponsor-initiated, randomized controlled clinical trial aims to demonstrate the clinical efficacy of RUS NE Surgical Navigation System in patients undergoing robotic-assisted partial nephrectomy. The trial will compare the experimental group (n=102) using RUS NE with a control group (n=102), aiming to show an 10% reduction in operation time. The study will involve 6 medical centers in South Korea in patient recruitment and evaluate the clinical efficacy and feasibility of the software, which has been shown to be reliable in previous studies. * Investigational Medical Device: RUS NE (Endoscopic Imaging Treatment Planning Software) * Clinical Trial duration: 24 months from IRB approval -Target number of subjects: Total of 204 participants
Sites
- Chonnam National University HospitalKwangju, Jeollanam-do, South Korea
- Asan Medical CenterSeoul, South Korea
- Samsung Medical CenterSeoul, South Korea
- Severance HospitalSeoul, South Korea